These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9767712)

  • 1. Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination.
    Prideaux CT; Pierce L; Krywult J; Hodgson AL
    Curr Microbiol; 1998 Nov; 37(5):324-32. PubMed ID: 9767712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC].
    Xu FZ; Shi AH; Chen XL; Yang B; Wang JL
    Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):923-7. PubMed ID: 18062275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the znuA virulence factor attenuates Actinobacillus pleuropneumoniae and confers protection against homologous or heterologous strain challenge.
    Yuan F; Liao Y; You W; Liu Z; Tan Y; Zheng C; BinWang ; Zhou D; Tian Y; Bei W
    Vet Microbiol; 2014 Dec; 174(3-4):531-539. PubMed ID: 25465668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
    Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
    J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.
    Prideaux CT; Lenghaus C; Krywult J; Hodgson AL
    Infect Immun; 1999 Apr; 67(4):1962-6. PubMed ID: 10085043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
    Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H
    Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine.
    Tonpitak W; Baltes N; Hennig-Pauka I; Gerlach GF
    Infect Immun; 2002 Dec; 70(12):7120-5. PubMed ID: 12438394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge.
    Xie F; Li G; Zhou L; Zhang Y; Cui N; Liu S; Wang C
    BMC Vet Res; 2017 Jan; 13(1):14. PubMed ID: 28061786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].
    Liu J; Chen Y; Hu L; Bei W; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):305-10. PubMed ID: 20518341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins.
    Chiers K; van Overbeke I; De Laender P; Ducatelle R; Carel S; Haesebrouck F
    Vet Q; 1998 Apr; 20(2):65-9. PubMed ID: 9563163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.
    Fu S; Ou J; Zhang M; Xu J; Liu H; Liu J; Yuan F; Chen H; Bei W
    Clin Vaccine Immunol; 2013 Feb; 20(2):134-9. PubMed ID: 23220998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
    Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
    Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
    Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S
    PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.
    Loera-Muro A; Angulo C
    Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.
    Shao M; Wang Y; Wang C; Guo Y; Peng Y; Liu J; Li G; Liu H; Liu S
    Acta Vet Scand; 2010 Sep; 52(1):52. PubMed ID: 20831818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals.
    Liu J; Chen X; Lin L; Tan C; Chen Y; Guo Y; Jin M; Guo A; Bei W; Chen H
    Vaccine; 2007 Nov; 25(44):7696-705. PubMed ID: 17767980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae.
    Nielsen R; van den Bosch JF; Plambeck T; Sørensen V; Nielsen JP
    Vet Microbiol; 2000 Jan; 71(1-2):81-7. PubMed ID: 10665536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.